WO2005074893A1 - Stable amorphous forms of montelukast sodium - Google Patents
Stable amorphous forms of montelukast sodium Download PDFInfo
- Publication number
- WO2005074893A1 WO2005074893A1 PCT/IL2005/000134 IL2005000134W WO2005074893A1 WO 2005074893 A1 WO2005074893 A1 WO 2005074893A1 IL 2005000134 W IL2005000134 W IL 2005000134W WO 2005074893 A1 WO2005074893 A1 WO 2005074893A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- amoφhous
- montelukast sodium
- condition
- solvent
- precipitate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2005210236A AU2005210236B2 (en) | 2004-02-03 | 2005-02-03 | Stable amorphous forms of montelukast sodium |
JP2006552007A JP2007520546A (en) | 2004-02-03 | 2005-02-03 | A stable amorphous form of Montelukast sodium |
CA002554927A CA2554927A1 (en) | 2004-02-03 | 2005-02-03 | Stable amorphous forms of montelukast sodium |
NZ548873A NZ548873A (en) | 2004-02-03 | 2005-02-03 | Stable amorphous forms of montelukast sodium |
EP05703177A EP1711166A1 (en) | 2004-02-03 | 2005-02-03 | Stable amorphous forms of montelukast sodium |
BRPI0506610-7A BRPI0506610A (en) | 2004-02-03 | 2005-02-03 | amorphous montelukast sodium, amorphous sodium montelukast preparation process, pharmaceutical composition, treatment method using the administration of amorphous montelukast sodium, amorphous montelukast amorphous co-precipitate and amorphous montelukast amorphous co-precipitate preparation process |
IL177123A IL177123A0 (en) | 2004-02-03 | 2006-07-27 | Stable amorphous forms of montelukast sodium |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54105204P | 2004-02-03 | 2004-02-03 | |
US60/541,052 | 2004-02-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005074893A1 true WO2005074893A1 (en) | 2005-08-18 |
Family
ID=34837451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2005/000134 WO2005074893A1 (en) | 2004-02-03 | 2005-02-03 | Stable amorphous forms of montelukast sodium |
Country Status (8)
Country | Link |
---|---|
US (1) | US7544805B2 (en) |
EP (1) | EP1711166A1 (en) |
JP (1) | JP2007520546A (en) |
AU (1) | AU2005210236B2 (en) |
BR (1) | BRPI0506610A (en) |
CA (1) | CA2554927A1 (en) |
NZ (1) | NZ548873A (en) |
WO (1) | WO2005074893A1 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006054317A1 (en) * | 2004-11-19 | 2006-05-26 | Matrix Laboratories Ltd | Process for the preparation of novel amorphous montelukast sodium |
WO2007059325A2 (en) * | 2005-11-16 | 2007-05-24 | Teva Pharmaceutical Industries Ltd. | Drying methods of montelukast sodium by azeotropic removal of the solvent |
EP1818057A1 (en) * | 2006-02-09 | 2007-08-15 | Teva Pharmaceutical Industries Ltd. | Stable pharmaceutical formulations of montelukast sodium |
US7544805B2 (en) | 2004-02-03 | 2009-06-09 | Chemagis Ltd. | Stable amorphous forms of montelukast sodium |
US7547787B2 (en) | 2004-04-21 | 2009-06-16 | Teva Pharmaceutical Industries Ltd. | Processes for preparing montelukast sodium |
JP2010500324A (en) * | 2006-08-09 | 2010-01-07 | エステヴェ キミカ, エス.エー. | Purification method of Montelukast |
US7812168B2 (en) | 2005-07-05 | 2010-10-12 | Teva Pharmaceutical Industries Ltd. | Purification of montelukast |
EP2287154A1 (en) | 2009-07-14 | 2011-02-23 | KRKA, D.D., Novo Mesto | Efficient synthesis for the preparation of montelukast |
WO2011033470A1 (en) | 2009-09-16 | 2011-03-24 | Ranbaxy Laboratories Limited | Crystalline form of montelukast sodium |
WO2011121091A1 (en) | 2010-03-31 | 2011-10-06 | Krka, D.D., Novo Mesto | Efficient synthesis for the preparation of montelukast and novel crystalline form of intermediates therein |
US8658208B2 (en) | 2010-02-26 | 2014-02-25 | Toray Industries, Inc. | Coated solid preparation |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101098678A (en) * | 2004-04-23 | 2008-01-02 | 锡德克斯公司 | Dpi formulation containing sulfoalkyl ether cyclodextrin |
US7629331B2 (en) | 2005-10-26 | 2009-12-08 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
PL1976522T5 (en) | 2005-12-30 | 2019-12-31 | Krka Tovarna Zdravil, D.D., Novo Mesto | Pharmaceutical composition containing montelukast |
ATE524444T1 (en) | 2006-04-12 | 2011-09-15 | Glade Organics Private Ltd | IMPROVED METHOD FOR PRODUCING MONTELUKAST SODIUM |
US8471030B2 (en) | 2010-12-06 | 2013-06-25 | Orochem Technologies Inc. | Purification of montelukast using simulated moving bed |
US9717684B2 (en) | 2014-04-25 | 2017-08-01 | R.P. Scherer Technologies, Llc | Stable montelukast solution |
CN107162969A (en) * | 2017-07-05 | 2017-09-15 | 成都亿知科技有限公司 | Montelukast sodium crystal and preparation method thereof and pharmaceutical composition |
KR20210042412A (en) | 2018-09-06 | 2021-04-19 | 주식회사 이노파마스크린 | Methods and compositions for treatment of asthma or Parkinson's disease |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0480717A1 (en) | 1990-10-12 | 1992-04-15 | Merck Frosst Canada Inc. | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
EP0508969A1 (en) | 1991-04-11 | 1992-10-14 | Astra Aktiebolag | Process for conditioning of water-soluble substances |
WO1995018107A1 (en) | 1993-12-28 | 1995-07-06 | Merck & Co., Inc. | Process for the preparation of leukotriene antagonists |
US6224907B1 (en) * | 1998-03-06 | 2001-05-01 | Alza Corporation | Anti-asthma therapy |
WO2003066598A1 (en) | 2002-02-07 | 2003-08-14 | Dr. Reddy's Laboratories Ltd. | Novel anhydrous amorphous forms of montelukast sodium salt |
WO2004108679A1 (en) | 2003-06-06 | 2004-12-16 | Morepen Laboratories Limited | An improved method for the preparation of montelukast acid and sodium salt thereof in amorphous form |
WO2005011595A2 (en) * | 2003-07-31 | 2005-02-10 | Epigenesis Pharmaceuticals Llc | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease |
WO2005040123A1 (en) * | 2003-10-10 | 2005-05-06 | Synhton B. V. | Solid-state montelukast |
Family Cites Families (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US655365A (en) | 1899-11-14 | 1900-08-07 | Henry M Johnson | Hernial truss. |
US4308351A (en) | 1980-04-18 | 1981-12-29 | Joseph Leighton | System for growing tissue cultures |
US5310674A (en) | 1982-05-10 | 1994-05-10 | Bar-Ilan University | Apertured cell carrier |
IL68507A (en) | 1982-05-10 | 1986-01-31 | Univ Bar Ilan | System and methods for cell selection |
US5272081A (en) | 1982-05-10 | 1993-12-21 | Bar-Ilan University | System and methods for cell selection |
US5681718A (en) | 1986-03-14 | 1997-10-28 | Celltech Limited | Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof |
JP2662215B2 (en) | 1986-11-19 | 1997-10-08 | 株式会社日立製作所 | Cell holding device |
GB2233928B (en) | 1989-05-23 | 1992-12-23 | Brother Ind Ltd | Apparatus and method for forming three-dimensional article |
US5635386A (en) | 1989-06-15 | 1997-06-03 | The Regents Of The University Of Michigan | Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture |
GB8927742D0 (en) | 1989-12-07 | 1990-02-07 | Diatec A S | Process and apparatus |
US5204055A (en) | 1989-12-08 | 1993-04-20 | Massachusetts Institute Of Technology | Three-dimensional printing techniques |
GB9215834D0 (en) | 1992-07-24 | 1992-09-09 | Celltech Ltd | Cell culture |
US5395588A (en) | 1992-12-14 | 1995-03-07 | Becton Dickinson And Company | Control of flow cytometer having vacuum fluidics |
US6206672B1 (en) | 1994-03-31 | 2001-03-27 | Edward P. Grenda | Apparatus of fabricating 3 dimensional objects by means of electrophotography, ionography or a similar process |
US5824536A (en) | 1994-08-23 | 1998-10-20 | St. Jude Children's Research Hospital | Influenza virus replicated in mammalian cell culture and vaccine production |
US5627045A (en) | 1995-04-12 | 1997-05-06 | Biolog, Inc. | Multi-test format with gel-forming matrix for characterization of microorganisms |
US6117612A (en) | 1995-04-24 | 2000-09-12 | Regents Of The University Of Michigan | Stereolithography resin for rapid prototyping of ceramics and metals |
US5905031A (en) | 1995-05-18 | 1999-05-18 | Coulter International Corp. | Identification of blast cells in a leukocyte cell preparation |
US5840565A (en) | 1995-08-22 | 1998-11-24 | The Regents Of The University Of California | Methods for enhancing the production of viral vaccines in PKR-deficient cell culture |
US6043092A (en) | 1996-03-18 | 2000-03-28 | University Of Pittsburgh | Cell culture media for mammalian cells |
US6103479A (en) | 1996-05-30 | 2000-08-15 | Cellomics, Inc. | Miniaturized cell array methods and apparatus for cell-based screening |
US6046426A (en) | 1996-07-08 | 2000-04-04 | Sandia Corporation | Method and system for producing complex-shape objects |
GB9620934D0 (en) | 1996-10-08 | 1996-11-27 | Molecular Drives Limited | Multi-well containers |
US5854684A (en) | 1996-09-26 | 1998-12-29 | Sarnoff Corporation | Massively parallel detection |
US6692961B1 (en) | 1996-10-11 | 2004-02-17 | Invitrogen Corporation | Defined systems for epithelial cell culture and use thereof |
US5885840A (en) | 1997-02-10 | 1999-03-23 | Compucyte Corp. | Multiple assays of cell specimens |
US6627426B2 (en) | 1997-02-14 | 2003-09-30 | Invitrogen Corporation | Methods for reducing adventitious agents and toxins and cell culture reagents produced thereby |
US6383810B2 (en) | 1997-02-14 | 2002-05-07 | Invitrogen Corporation | Dry powder cells and cell culture reagents and methods of production thereof |
US5869673A (en) * | 1997-02-28 | 1999-02-09 | Merck & Co., Inc. | Process for 3-(2-(7-chloro-2-quinolinyl)ethenyl) - benzaldehyde |
US5952347A (en) * | 1997-03-13 | 1999-09-14 | Merck & Co., Inc. | Quinoline leukotriene antagonists |
KR100266448B1 (en) | 1997-06-26 | 2000-09-15 | 박종헌 | Mass production of taxol by changing temperature during the plant cell culture |
US6066285A (en) | 1997-12-12 | 2000-05-23 | University Of Florida | Solid freeform fabrication using power deposition |
US6210910B1 (en) | 1998-03-02 | 2001-04-03 | Trustees Of Tufts College | Optical fiber biosensor array comprising cell populations confined to microcavities |
ATE227338T1 (en) | 1998-03-18 | 2002-11-15 | Massachusetts Inst Technology | VASCULARIZED PERFUSED ARRANGEMENTS FOR MICRO TISSUES AND MICRO ORGANS |
US6378527B1 (en) | 1998-04-08 | 2002-04-30 | Chondros, Inc. | Cell-culture and polymer constructs |
US6528286B1 (en) | 1998-05-29 | 2003-03-04 | Genentech, Inc. | Mammalian cell culture process for producing glycoproteins |
FR2779443B1 (en) | 1998-06-08 | 2000-08-04 | Claude Hanni | ORGANIC CELL CULTURE AND STUDY OF THEIR ELECTROPHYSIOLOGICAL ACTIVITY AND MEMBRANE DEVICE USED IN SUCH A DEVICE |
AT407047B (en) | 1998-08-03 | 2000-11-27 | Pfaller Walter Dr | CELL CULTURE DEVICE |
KR100271208B1 (en) | 1998-08-13 | 2000-12-01 | 윤덕용 | Selective infiltration manufacturing method and apparatus |
AU5366499A (en) | 1998-08-19 | 2000-03-14 | Ontario Cancer Institute, The | The use of high frequency ultrasound imaging to detect and monitor the process of apoptosis in living tissues, (ex-vivo) tissues and cell-culture |
US6342384B1 (en) | 1998-08-21 | 2002-01-29 | The University Of Va Patent Foundation | Production of adenoviral vectors using serum-free suspension cell culture in a hollow fiber system |
DE29817223U1 (en) | 1998-09-24 | 1998-11-19 | Marotzki Stefan Dr | Device for taking up a cell culture |
US6228437B1 (en) | 1998-12-24 | 2001-05-08 | United Technologies Corporation | Method for modifying the properties of a freeform fabricated part |
US6492148B1 (en) | 1999-03-05 | 2002-12-10 | Akzo Nobel Nv | Genetically engineered cell culture adapted infectious bursal disease virus (IBDV) mutants |
US6455310B1 (en) | 1999-03-23 | 2002-09-24 | Biocrystal Ltd. | Cell culture apparatus and method for culturing cells |
US6410309B1 (en) | 1999-03-23 | 2002-06-25 | Biocrystal Ltd | Cell culture apparatus and methods of use |
EP1171615B1 (en) | 1999-04-26 | 2006-12-13 | Genentech, Inc. | Cell culture process for glycoproteins |
US6338964B1 (en) | 1999-05-07 | 2002-01-15 | Bayer Corporation | Process and medium for mammalian cell culture under low dissolved carbon dioxide concentration |
US6372494B1 (en) | 1999-05-14 | 2002-04-16 | Advanced Tissue Sciences, Inc. | Methods of making conditioned cell culture medium compositions |
WO2000073417A1 (en) | 1999-05-27 | 2000-12-07 | The Research Foundation Of State University Of New York | In vitro cell culture device including cartilage and methods of using the same |
JP2001037472A (en) | 1999-07-28 | 2001-02-13 | Bio Quest:Kk | Three dimensional cell-culturing base medium and cell culture using the same |
US6333192B1 (en) | 1999-08-09 | 2001-12-25 | North Carolina State University | Method of producing an undifferentiated avian cell culture using avian primordial germ cells |
AU784506B2 (en) | 1999-08-25 | 2006-04-13 | Immunex Corporation | Compositions and methods for improved cell culture |
AU1592501A (en) | 1999-11-10 | 2001-06-06 | Massachusetts Institute Of Technology | Cell analysis and sorting apparatus for manipulation of cells |
US6649408B2 (en) | 2000-03-24 | 2003-11-18 | George Mason University | Microdroplet cell culture technique |
IL136232A0 (en) | 2000-05-18 | 2001-05-20 | Bar Ilan University Res Author | Measurements of enzymatic activity in a single, individual cell in population |
KR20010110945A (en) | 2000-06-09 | 2001-12-15 | 김정용 | Method for penile augmentation with autodermal cell culture |
US6670184B2 (en) | 2000-06-23 | 2003-12-30 | Basf Ag | Method for producing a lipid emulsion for use in insect cell culture |
US6635448B2 (en) | 2000-08-21 | 2003-10-21 | Clonexdevelopment, Inc. | Methods and compositions for increasing protein yield from a cell culture |
US7208120B2 (en) | 2000-09-27 | 2007-04-24 | The Trustees Of Boston University | Cellular diagnostic arrays, methods of using and processing for producing same |
US7211209B2 (en) | 2000-11-08 | 2007-05-01 | Surface Logix, Inc. | Method of making device for arraying biomolecules and for monitoring cell motility in real-time |
US6588586B2 (en) | 2000-12-08 | 2003-07-08 | Biocrystal Ltd | Mailer for cell culture device |
US6376148B1 (en) | 2001-01-17 | 2002-04-23 | Nanotek Instruments, Inc. | Layer manufacturing using electrostatic imaging and lamination |
US6403369B1 (en) | 2001-01-19 | 2002-06-11 | Gary W. Wood | Cell culture vessel |
US20020106715A1 (en) | 2001-02-02 | 2002-08-08 | Medisel Ltd | System and method for collecting data from individual cells |
US20020151562A1 (en) * | 2001-02-05 | 2002-10-17 | Seligman Morton J. | Compositions and methods for treating allergic fungal sinusitis |
US6645757B1 (en) | 2001-02-08 | 2003-11-11 | Sandia Corporation | Apparatus and method for transforming living cells |
DE10119718A1 (en) * | 2001-04-21 | 2002-10-31 | Boehringer Ingelheim Pharma | Process for the continuous production of inhalable medicinal substances, device for carrying out the process and medicinal substance produced by this process |
WO2002092778A2 (en) | 2001-05-17 | 2002-11-21 | The Board Of Trustees Of The Leland Stanford Junior University | Device and method for three-dimensional spatial localization and functional interconnection of different types of cells |
KR20020088848A (en) | 2001-05-21 | 2002-11-29 | (주)코아바이오텍 | Cell Culture Tube and Multiple Roller Tube Cell Culture System Using The Same |
WO2003008943A1 (en) | 2001-07-19 | 2003-01-30 | Tufts University | Optical array device and methods of use thereof for screening, analysis and manipulation of particles |
US7285412B2 (en) | 2001-07-27 | 2007-10-23 | Surface Logix Inc. | Device for magnetic immobilization of cells |
US20050014201A1 (en) | 2001-10-25 | 2005-01-20 | Mordechai Deuthsch | Interactive transparent individual cells biochip processor |
WO2003056330A2 (en) | 2001-12-31 | 2003-07-10 | Institut für Physikalische Hochtechnologie e.V. | Cell sorting system for the size-based sorting or separation of cells suspended in a flowing fluid |
AU2003244451A1 (en) * | 2002-02-04 | 2003-09-02 | Glaxo Group Limited | Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form |
US20030189850A1 (en) | 2002-04-09 | 2003-10-09 | Toyo Boseki Kabushiki Kaisha | Cell array system |
IL154677A0 (en) | 2003-02-27 | 2003-09-17 | Univ Bar Ilan | A method and apparatus for manipulating an individual cell |
JP2004344036A (en) | 2003-05-21 | 2004-12-09 | Fujitsu Ltd | Substance-transducing device and substance-transducing system |
WO2005007796A2 (en) | 2003-07-21 | 2005-01-27 | Molecular Cytomics Ltd. | Improved multiwell plate |
WO2004113492A1 (en) | 2003-06-26 | 2004-12-29 | Molecular Cytomics Ltd. | Improved materials for constructing cell-chips, cell-chip covers, cell-chip coats, processed cell-chips and uses thereof |
US20050064524A1 (en) | 2003-08-11 | 2005-03-24 | Mordechai Deutsch | Population of cells utilizable for substance detection and methods and devices using same |
BRPI0506610A (en) | 2004-02-03 | 2007-05-02 | Chemagis Ltd | amorphous montelukast sodium, amorphous sodium montelukast preparation process, pharmaceutical composition, treatment method using the administration of amorphous montelukast sodium, amorphous montelukast amorphous co-precipitate and amorphous montelukast amorphous co-precipitate preparation process |
-
2005
- 2005-02-03 BR BRPI0506610-7A patent/BRPI0506610A/en not_active IP Right Cessation
- 2005-02-03 AU AU2005210236A patent/AU2005210236B2/en not_active Ceased
- 2005-02-03 JP JP2006552007A patent/JP2007520546A/en active Pending
- 2005-02-03 NZ NZ548873A patent/NZ548873A/en unknown
- 2005-02-03 US US11/048,746 patent/US7544805B2/en not_active Expired - Fee Related
- 2005-02-03 WO PCT/IL2005/000134 patent/WO2005074893A1/en active Application Filing
- 2005-02-03 CA CA002554927A patent/CA2554927A1/en not_active Abandoned
- 2005-02-03 EP EP05703177A patent/EP1711166A1/en not_active Ceased
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0480717A1 (en) | 1990-10-12 | 1992-04-15 | Merck Frosst Canada Inc. | Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists |
EP0508969A1 (en) | 1991-04-11 | 1992-10-14 | Astra Aktiebolag | Process for conditioning of water-soluble substances |
WO1995018107A1 (en) | 1993-12-28 | 1995-07-06 | Merck & Co., Inc. | Process for the preparation of leukotriene antagonists |
US6224907B1 (en) * | 1998-03-06 | 2001-05-01 | Alza Corporation | Anti-asthma therapy |
WO2003066598A1 (en) | 2002-02-07 | 2003-08-14 | Dr. Reddy's Laboratories Ltd. | Novel anhydrous amorphous forms of montelukast sodium salt |
WO2004108679A1 (en) | 2003-06-06 | 2004-12-16 | Morepen Laboratories Limited | An improved method for the preparation of montelukast acid and sodium salt thereof in amorphous form |
WO2005011595A2 (en) * | 2003-07-31 | 2005-02-10 | Epigenesis Pharmaceuticals Llc | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease |
WO2005040123A1 (en) * | 2003-10-10 | 2005-05-06 | Synhton B. V. | Solid-state montelukast |
Non-Patent Citations (1)
Title |
---|
YU, ADVANCED DRUG DELIVERY REVIEWS, vol. 48, 2001, pages 27 - 42 |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7544805B2 (en) | 2004-02-03 | 2009-06-09 | Chemagis Ltd. | Stable amorphous forms of montelukast sodium |
US7547787B2 (en) | 2004-04-21 | 2009-06-16 | Teva Pharmaceutical Industries Ltd. | Processes for preparing montelukast sodium |
WO2006054317A1 (en) * | 2004-11-19 | 2006-05-26 | Matrix Laboratories Ltd | Process for the preparation of novel amorphous montelukast sodium |
US7812168B2 (en) | 2005-07-05 | 2010-10-12 | Teva Pharmaceutical Industries Ltd. | Purification of montelukast |
WO2007059325A2 (en) * | 2005-11-16 | 2007-05-24 | Teva Pharmaceutical Industries Ltd. | Drying methods of montelukast sodium by azeotropic removal of the solvent |
WO2007059325A3 (en) * | 2005-11-16 | 2007-07-26 | Teva Pharma | Drying methods of montelukast sodium by azeotropic removal of the solvent |
JP2013049709A (en) * | 2006-02-09 | 2013-03-14 | Teva Pharmaceutical Industries Ltd | Pharmaceutical preparation with stabilized montelukast sodium |
EP1818057A1 (en) * | 2006-02-09 | 2007-08-15 | Teva Pharmaceutical Industries Ltd. | Stable pharmaceutical formulations of montelukast sodium |
WO2007092031A1 (en) * | 2006-02-09 | 2007-08-16 | Teva Pharmaceutical Industries Ltd. | Stable pharmaceutical formulations of montelukast sodium |
JP2009526047A (en) * | 2006-02-09 | 2009-07-16 | テバ ファーマシューティカル インダストリーズ リミティド | Stable pharmaceutical formulation of Montelukast sodium |
EP2158911A1 (en) * | 2006-02-09 | 2010-03-03 | Teva Pharmaceutical Industries Ltd | Stable pharmaceutical formulations of montelukast sodium |
JP2010500324A (en) * | 2006-08-09 | 2010-01-07 | エステヴェ キミカ, エス.エー. | Purification method of Montelukast |
EP2287154A1 (en) | 2009-07-14 | 2011-02-23 | KRKA, D.D., Novo Mesto | Efficient synthesis for the preparation of montelukast |
WO2011033470A1 (en) | 2009-09-16 | 2011-03-24 | Ranbaxy Laboratories Limited | Crystalline form of montelukast sodium |
US8658208B2 (en) | 2010-02-26 | 2014-02-25 | Toray Industries, Inc. | Coated solid preparation |
WO2011121091A1 (en) | 2010-03-31 | 2011-10-06 | Krka, D.D., Novo Mesto | Efficient synthesis for the preparation of montelukast and novel crystalline form of intermediates therein |
Also Published As
Publication number | Publication date |
---|---|
JP2007520546A (en) | 2007-07-26 |
US7544805B2 (en) | 2009-06-09 |
BRPI0506610A (en) | 2007-05-02 |
EP1711166A1 (en) | 2006-10-18 |
US20050187245A1 (en) | 2005-08-25 |
AU2005210236A1 (en) | 2005-08-18 |
NZ548873A (en) | 2010-04-30 |
AU2005210236B2 (en) | 2010-09-09 |
CA2554927A1 (en) | 2005-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005210236B2 (en) | Stable amorphous forms of montelukast sodium | |
DK1937642T3 (en) | Crystals of sodium laquinimod and the process for its preparation | |
EP1678139B1 (en) | Solid-state montelukast | |
US20080014280A1 (en) | Amorphous pregabalin and process for the preparation thereof | |
US7625911B2 (en) | Amorphous form of erlotinib hydrochloride and its solid amorphous dispersion | |
WO2011095059A1 (en) | Polymorphs of dasatinib, preparation methods and pharmaceutical compositions thereof | |
EP2820000B1 (en) | Besylate and tosylate salts of a dihydroquinazoline derivative and their use as antiviral agents | |
WO2013127971A1 (en) | Sodium and calcium salts of a dihydroquinazoline derivative and use thereof as antiviral agents | |
US7351710B2 (en) | Preparation of amorphous form of indiplon | |
US7897613B2 (en) | Crystalline polymorphs of clopidogrel | |
US8115015B2 (en) | Process for the preparation of amorphous atorvastatin calcium | |
US20040063782A1 (en) | Bicalutamide forms | |
WO2007148137A1 (en) | Novel hydrate form of moxifloxacin monohydrochloride | |
KR20070001946A (en) | 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolonone monohydrochloride in crystalline form and the process for its preparation | |
US20100260851A1 (en) | Novel Polymorph of Atorvastatin Calcium and Use Thereof for the Preparation of Amorphous Atorvastatin Calcium | |
US20230312485A1 (en) | A precipitation process for amorphous letermovir | |
US20080146809A1 (en) | Process for the Preparation of Novel Amorphous Montelukast Sodium | |
EP1902030B1 (en) | Substituted quinolones ii | |
WO2018134843A1 (en) | Polymorphic forms of (e)-n-{4-[3-chloro-4-((pyridin-2-yl methoxy)anilino]-3-cyano-7- ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide, its maleate salt and process for preparation thereof | |
US20080014263A1 (en) | Amorphous eprosartan mesylate and process for the preparation thereof | |
WO2018029699A1 (en) | Solid state forms of (2e)-n-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide and process for preparation thereof | |
CN116323556A (en) | Antimicrobial and antiviral sulfur-containing monoglyceride derivatives | |
CN113698420A (en) | Novel crystal form of bicalutavir sodium and preparation method thereof | |
WO2016147206A1 (en) | Process for the preparation of amorphous idelalisib and its premix | |
US8754129B2 (en) | Crystalline vorinostat form VI |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 177123 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2554927 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005703177 Country of ref document: EP Ref document number: 548873 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006552007 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005210236 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2005210236 Country of ref document: AU Date of ref document: 20050203 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005210236 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2005703177 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0506610 Country of ref document: BR |